{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:56:13Z","timestamp":1789736173345,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s10620-017-4860-z","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T01:39:44Z","timestamp":1515721184000},"page":"653-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study"],"prefix":"10.1007","volume":"63","author":[{"given":"Jennifer H.","family":"Benbow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April D.","family":"Elam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae L.","family":"Massengill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Brandon-Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"Culberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"deLemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura W.","family":"Schrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"4860_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12:145.","journal-title":"BMC Med"},{"key":"4860_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ajg.2017.05.005","volume":"18","author":"MA Serafy El","year":"2017","unstructured":"El Serafy MA, Kassem AM, Omar H, Mahfouz MS, Maissa El Said EL. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: systematic review and meta-analysis. Arab J Gastroenterol. 2017;18:51\u201357.","journal-title":"Arab J Gastroenterol"},{"key":"4860_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/liv.12734","volume":"35","author":"ML Shiffman","year":"2015","unstructured":"Shiffman ML, Benhamou Y. Cure of HCV related liver disease. Liver Int. 2015;35:71\u201377.","journal-title":"Liver Int"},{"key":"4860_CR4","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","volume":"13","author":"AG Singal","year":"2015","unstructured":"Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol. 2015;13:2140\u20132151.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4860_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"4860_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2893.2008.01052.x","volume":"16","author":"SA Gonzalez","year":"2009","unstructured":"Gonzalez SA, Fiel MI, Sauk J, et al. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J Viral Hepat. 2009;16:141\u2013148.","journal-title":"J Viral Hepat"},{"key":"4860_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2014.03.012","volume":"107","author":"YA Lee","year":"2014","unstructured":"Lee YA, Friedman SL. Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C? Antiviral Res. 2014;107:23\u201330.","journal-title":"Antiviral Res"},{"key":"4860_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","volume":"65","author":"M Mandorfer","year":"2016","unstructured":"Mandorfer M, Kozbial K, Schwabl P, et al. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J Hepatol. 2016;65:692\u2013699.","journal-title":"J Hepatol"},{"key":"4860_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/liv.13016","volume":"36","author":"L Serfaty","year":"2016","unstructured":"Serfaty L. Follow-up of patients with chronic hepatitis C and a sustained viral response. Liver Int. 2016;36:67\u201371.","journal-title":"Liver Int"},{"key":"4860_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/liv.13106","volume":"36","author":"R D\u2019Ambrosio","year":"2016","unstructured":"D\u2019Ambrosio R, Colombo M. Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression? Liver Int. 2016;36:783\u2013790.","journal-title":"Liver Int"},{"key":"4860_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.28535","volume":"64","author":"HB El-Serag","year":"2016","unstructured":"El-Serag HB, Kanwal F, Richardson P, Kramer J. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology. 2016;64:130\u2013137.","journal-title":"Hepatology"},{"key":"4860_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000445330","volume":"32","author":"MD Schneider","year":"2016","unstructured":"Schneider MD, Sarrazin C. Management of HCV-associated liver cirrhosis. Visc Med. 2016;32:96\u2013104.","journal-title":"Visc Med"},{"key":"4860_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830\u2013841.","journal-title":"Gut"},{"key":"4860_CR14","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s00018-011-0783-6","volume":"68","author":"KS Midwood","year":"2011","unstructured":"Midwood KS, Hussenet T, Langlois B, Orend G. Advances in tenascin-C biology. Cell Mol Life Sci. 2011;68:3175\u20133199.","journal-title":"Cell Mol Life Sci"},{"key":"4860_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1600-0676.1994.tb00064.x","volume":"14","author":"M Yamauchi","year":"1994","unstructured":"Yamauchi M, Mizuhara Y, Maezawa Y, Toda G. Serum tenascin levels in chronic liver disease. Liver. 1994;14:148\u2013153.","journal-title":"Liver"},{"key":"4860_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ajpath.2015.09.015","volume":"186","author":"JH Benbow","year":"2016","unstructured":"Benbow JH, Thompson KJ, Cope HL, et al. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C\/Toll-Like Receptor 4 Signaling. Am J Pathol. 2016;186:145\u2013158.","journal-title":"Am J Pathol"},{"key":"4860_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1478-3231.2005.01229.x","volume":"26","author":"H Tanaka","year":"2006","unstructured":"Tanaka H, El-Karef A, Kaito M, et al. Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C. Liver Int. 2006;26:311\u2013318.","journal-title":"Liver Int"},{"key":"4860_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u2013845.","journal-title":"Biometrics"},{"key":"4860_CR19","first-page":"751","volume":"8","author":"Y Peng","year":"2015","unstructured":"Peng Y, Qi X, Dai J, Li H, Guo X. Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med. 2015;8:751\u2013757.","journal-title":"Int J Clin Exp Med"},{"key":"4860_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-2008-1040325","volume":"28","author":"F Durand","year":"2008","unstructured":"Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis. 2008;28:110\u2013122.","journal-title":"Semin Liver Dis"},{"key":"4860_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acc.2015.03.001","volume":"70","author":"SH Park","year":"2015","unstructured":"Park SH, Bang CS, Kim DJ. Biomarkers in HCV infection. Adv Clin Chem. 2015;70:131\u2013196.","journal-title":"Adv Clin Chem"},{"key":"4860_CR22","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1111\/liv.12871","volume":"35","author":"GS Jung","year":"2015","unstructured":"Jung GS, Jeon JH, Choi YK, et al. Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells. Liver Int. 2015;35:2233\u20132245.","journal-title":"Liver Int"},{"key":"4860_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.3184","volume":"19","author":"DL Thomas","year":"2013","unstructured":"Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med. 2013;19:850\u2013858.","journal-title":"Nat Med"},{"key":"4860_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jgh.12023","volume":"28","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li J, Wang X, Sang M, Ho W. Hepatic stellate cells, liver innate immunity, and hepatitis C virus. J Gastroenterol Hepatol. 2013;28:112\u2013115.","journal-title":"J Gastroenterol Hepatol"},{"key":"4860_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4158\/EP12195.RA","volume":"19","author":"DL Nguyen","year":"2013","unstructured":"Nguyen DL, Hu KQ. Clinical monitoring of chronic hepatitis C based on its natural history and therapy. Endocr Pract. 2013;19:292\u2013300.","journal-title":"Endocr Pract"},{"key":"4860_CR26","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/hep.510230607","volume":"23","author":"M Yano","year":"1996","unstructured":"Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23:1334\u20131340.","journal-title":"Hepatology"},{"key":"4860_CR27","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1111\/j.1572-0241.2008.01948.x","volume":"103","author":"G Bedogni","year":"2008","unstructured":"Bedogni G, Miglioli L, Masutti F, et al. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. Am J Gastroenterol. 2008;103:2248\u20132253.","journal-title":"Am J Gastroenterol"},{"key":"4860_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2016.04.031","volume":"65","author":"H Vandenbulcke","year":"2016","unstructured":"Vandenbulcke H, Moreno C, Colle I, et al. Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study. J Hepatol. 2016;65:543\u2013551.","journal-title":"J Hepatol"},{"key":"4860_CR29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1053\/j.gastro.2005.03.089","volume":"129","author":"A Schulze-Krebs","year":"2005","unstructured":"Schulze-Krebs A, Preimel D, Popov Y, et al. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology. 2005;129:246\u2013258.","journal-title":"Gastroenterology"},{"key":"4860_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/labinvest.2012.54","volume":"92","author":"A Glassner","year":"2012","unstructured":"Glassner A, Eisenhardt M, Kramer B, et al. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Lab Invest. 2012;92:967\u2013977.","journal-title":"Lab Invest"},{"key":"4860_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ncpgasthep0961","volume":"4","author":"JA Mengshol","year":"2007","unstructured":"Mengshol JA, Golden-Mason L, Rosen HR. Mechanisms of disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol. 2007;4:622\u2013634.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"4860_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jhep.2006.10.011","volume":"46","author":"A El-Karef","year":"2007","unstructured":"El-Karef A, Kaito M, Tanaka H, et al. Expression of large tenascin-C splice variants by hepatic stellate cells\/myofibroblasts in chronic hepatitis C. J Hepatol. 2007;46:664\u2013673.","journal-title":"J Hepatol"},{"key":"4860_CR33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","volume":"64","author":"WR Kim","year":"2016","unstructured":"Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016;64:773\u2013780.","journal-title":"J Hepatol"},{"key":"4860_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.27382","volume":"61","author":"G Xiao","year":"2015","unstructured":"Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61:292\u2013302.","journal-title":"Hepatology"},{"key":"4860_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12879-015-0748-8","volume":"15","author":"J Smith-Palmer","year":"2015","unstructured":"Smith-Palmer J, Cerri K, Valentine W. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infect Dis. 2015;15:19.","journal-title":"BMC Infect Dis"},{"key":"4860_CR36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cgh.2011.04.027","volume":"9","author":"AF Carrion","year":"2011","unstructured":"Carrion AF, Ghanta R, Carrasquillo O, Martin P. Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol. 2011;9:834\u2013841. quiz e109-810.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4860_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jama.2014.7085","volume":"312","author":"A Kohli","year":"2014","unstructured":"Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312:631\u2013640.","journal-title":"JAMA"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4860-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T19:42:29Z","timestamp":1547235749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4860-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4860"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4860-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"16 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors do not have any disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}